INS and polycystic ovary syndrome: Beyond its established role in tumor suppression, PDCD4 dysregulation has been implicated in various metabolic diseases, including polycystic ovary syndrome (PCOS), obesity, diabetes, and atherosclerosis, where it affects glucose and lipid metabolism, insulin resistance, inflammation, oxidative stress, and gut microbiota homeostasis.